Resurgence of measles virus infection in an eliminated country, Sri Lanka

Abstract

Objective: To describe the situation of measles in Sri Lanka from May to November, 2023 and to define the role of virology laboratory towards case confirmation and epidemiological and genetic characterization of the outbreak.

Methods: This retrospective study analyzed all samples tested for measles from 1st of May to 30th of November, 2023 at National Measles Rubella Laboratory, Sri Lanka. According to the World Health Organization (WHO) algorithm, serum and oropharyngeal/nasopharyngeal swabs were tested with WHO recommended kits for anti-measles IgM and measles virus specific RNA, respectively. Selected RNA positive samples were sequenced at reference laboratory, India. Analysis of sequencing data and construction of phylogenetic tree were carried out at National Measles Rubella Laboratory. Data was analyzed using descriptive statistics.

Results: Of the total 1132 serum samples and 497 oropharyngeal/nasopharyngeal swabs from 1326 patients, 657 (49.5%) patients were confirmed as measles by anti-measles IgM, measles virus specific RNA or both. Males (55.6%, n=365) and the age group from >20 to ≤30 years (33.0%, n=217) predominated positive patients. All provinces reported measles positive cases. All samples sequenced (100%, n=42) were genotype D8 with 95.2% (n=40) bearing Victoria. Australia origin.

Conclusions: We described resurgence of measles in an eliminated country, confirming the genotype to be D8, one of the two genotypes currently circulating globally. Further, the study strongly convinced the importance of a strengthened virological surveillance system in an eliminated country, despite its eliminated status.

Keywords

Measles elimination / Resurgence of measles / Sri Lanka / Genotype D8 / National Measles Rubella Laboratory

References

[1] Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, et al. Progress toward measles elimination worldwide, 2000-2022. MMWR Morb Mortal Wkly Rep 2023; 72(46): 1262-1268.

[2] Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, et al. Genetic characterization of measles and rubella viruses detected through global measles and rubella elimination surveillance, 2016-2018. MMWR Morb Mortal Wkly Rep 2019; 68: 587-591. doi: 10.15585/mmwr.mm6826a3.

[3] World Health Organization. Measles and rubella global update, distribution of measles genotypes (last 12 months). MeaNS2 database (genotypes) and IVB database (incidence) as of 2023-09-12,WHO immunization data portal. [Online]. Available from: https://immunizationdata.who.int/assets/measlesrubella/Global_MR_Update_May_2023_SA.pptx. [Accessed on 9 January 2024].

[4] World Health Organisation. Sri Lanka eliminates measles, News release, India, 9 July 2019. [Online]. Available from: https://www.who.int/southeastasia/news/detail/09-07-2019-sri-lanka-eliminates-measles#:~:text=New%20Delhi%3A%20The%20World%20Health,globally%20measles%20cases%20are%20increasing. [Accessed on 20 January 2024].

[5] World Health Organization. Striving to eliminate measles and rubella in the WHO South-East Asia Region, 3 May 2023. [Online]. Available from: https://www.who.int/southeastasia/news/feature-stories/detail/striving-to-eliminate-measles-and-rubella-in-the-who-south-east-asia-region#:~:text=The%20challenges%20to%20achieve%20measles,remained%20limited%20in%20endemic%20countries. [Accessed on 10 January 2024].

[6] Samaraweera B, Mahanama A, Ahamad AZ, Wimalaratne GI, Abeynayake J. The laboratory investigation of a measles outbreak in the eve of its elimination in Sri Lanka. J Clin Virol 2020; 122: 104230.

[7] Hübschen JM, Bork SM, Brown KE, Mankertz A, Santibanez S, Mamou MB, et al. Challenges of measles and rubella laboratory diagnostics in the era of elimination. Clin Microbiol Infect 2017; 23(8): 511-515.

[8] Centers for Disease Control and Prevention. Genetic analysis of measles viruses. [Online]. Available from: https://www.cdc.gov/measles/lab-tools/genetic-analysis.html#:~:text=Measles%20virus%20genotyping%20can%20play,the%20connection%20is%20not%20obvious. [Accessed on 17 January 2024].

[9] Green MS, Schwartz N, Peer V. Gender differences in measles incidence rates in a multi-year, pooled analysis, based on national data from seven high income countries. BMC Infect Dis 2022; 22(1): 358.

[10] Sri Lanka Medical Association. Guidelines and information on vaccines. [Online]. Available from: https://slma.lk/wp-content/uploads/2014/12/Guidelines-and-information-on-vaccines.pdf. [Accessed on 13 January 2024].

[11] Ministry of Health. Nutrition and indigenous medicine, circular on measles, rubella, and congenital rubella syndrome elimination initiative, Sri Lanka, February, 2017. [Online]. Available from: https://www.epid.gov.lk/storage/post/pdfs/measles%20_rubella_crs_guidelines_2017.pdf. [Accessed on 13 January 2024].

[12] Hackethal V. Passive measles immunity wanes quickly in infants, medscape infectious diseases, November 21, 2019. [Online]. Available from: https://www.medscape.com/viewarticle/921664?form=fpf. [Accessed on 13 January 2024].

[13] Szenborn L, Tischer A, Pejcz J, Rudkowski Z, Wójcik M. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Med Sci Monit 2003; 9(12): CR541-CR546.

[14] Rocke Z, Belyayeva M. Subacute sclerosing panencephalitis, StatPearls Publishing; January, 2024. [Online]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560673/. [Accessed on 28 January 2024].